These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2253682

  • 1. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
    Flescher E, Fossum D, Ballester A, Maizel A, Sharma S, Talal N.
    Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
    [Abstract] [Full Text] [Related]

  • 2. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
    Delfraissy JF, Wallon C, Vazquez A, Dugas B, Dormont J, Galanaud P.
    Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.
    Kitani A, Hara M, Hirose T, Norioka K, Harigai M, Hirose W, Suzuki K, Kawakami M, Kawagoe M, Nakamura H.
    Clin Exp Immunol; 1989 Jul; 77(1):31-6. PubMed ID: 2788539
    [Abstract] [Full Text] [Related]

  • 4. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.
    Ueda Y, Sakane T, Tsunematsu T.
    J Immunol; 1989 Dec 15; 143(12):3988-93. PubMed ID: 2592765
    [Abstract] [Full Text] [Related]

  • 5. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
    Ohtsuka K, Gray JD, Stimmler MM, Toro B, Horwitz DA.
    J Immunol; 1998 Mar 01; 160(5):2539-45. PubMed ID: 9498800
    [Abstract] [Full Text] [Related]

  • 6. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S, Giudizi GM, Maggi E, Almerigogna F, Biagiotti R, Del Prete G, Mazzetti M, Alessi A, Vercelli D, Ricci M.
    Eur J Immunol; 1985 Dec 01; 15(12):1158-64. PubMed ID: 3936718
    [Abstract] [Full Text] [Related]

  • 7. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.
    Martinez-Cordero E, Alcocer-Varela J, Alarcon-Segovia D.
    Clin Exp Immunol; 1986 Sep 01; 65(3):598-604. PubMed ID: 3490941
    [Abstract] [Full Text] [Related]

  • 8. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
    Kumar A, Rogers T, Maizel A, Sharma S.
    J Immunol; 1991 Aug 01; 147(3):998-1006. PubMed ID: 1713611
    [Abstract] [Full Text] [Related]

  • 9. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
    Hirose T.
    Ryumachi; 1989 Aug 01; 29(4):277-83. PubMed ID: 2617369
    [Abstract] [Full Text] [Related]

  • 10. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL, Thorbecke GJ.
    Eur J Immunol; 1989 Feb 01; 19(2):365-71. PubMed ID: 2495224
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
    Petit-Koskas E, Génot E, Lawrence D, Kolb JP.
    Eur J Immunol; 1988 Jan 01; 18(1):111-6. PubMed ID: 3257917
    [Abstract] [Full Text] [Related]

  • 12. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A, Gérard JP, Olive D, Auffredou MT, Dugas B, Karray S, Delfraissy JF, Galanaud P.
    Eur J Immunol; 1986 Dec 01; 16(12):1503-7. PubMed ID: 3102243
    [Abstract] [Full Text] [Related]

  • 13. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
    Kallenberg CG, van Dissel-Emiliani F, Huitema MG, Limburg PC, The TH.
    J Clin Lab Immunol; 1988 Jun 01; 26(2):55-61. PubMed ID: 3264025
    [Abstract] [Full Text] [Related]

  • 14. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ, Muraguchi A, Hong JX, Butler JL, Dinarello CA, Fauci AS.
    J Immunol; 1983 Aug 01; 131(2):801-5. PubMed ID: 6602846
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S, Giudizi GM, Almerigogna F, Biagiotti R, Alessi A, Mingari C, Liang CM, Moretta L, Ricci M.
    Eur J Immunol; 1986 Jun 01; 16(6):623-9. PubMed ID: 3087756
    [Abstract] [Full Text] [Related]

  • 16. Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4.
    Vazquez A, Mills S, Maizel A.
    J Immunol; 1989 Jan 01; 142(1):94-9. PubMed ID: 2783328
    [Abstract] [Full Text] [Related]

  • 17. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N, Tsuchida T, Tamaki K.
    Arthritis Rheum; 1999 Feb 01; 42(2):328-37. PubMed ID: 10025928
    [Abstract] [Full Text] [Related]

  • 18. CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
    Néron S, Boire G, Dussault N, Racine C, de Brum-Fernandes AJ, Côté S, Jacques A.
    Arch Immunol Ther Exp (Warsz); 2009 Feb 01; 57(6):447-58. PubMed ID: 19866343
    [Abstract] [Full Text] [Related]

  • 19. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
    Funauchi M, Sugishima H, Minoda M, Horiuchi A.
    J Rheumatol; 1991 Mar 01; 18(3):368-72. PubMed ID: 1906936
    [Abstract] [Full Text] [Related]

  • 20. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation.
    Ehrhardt RO, Strober W, Harriman GR.
    J Immunol; 1992 Jun 15; 148(12):3830-6. PubMed ID: 1602131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.